Christopher J.  Reading net worth and biography

Christopher Reading Biography and Net Worth

Chris joined USPh as Chief Operating Officer in November 2003. In November 2004, Chris was promoted to President, Chief Executive Officer and joined the Board of Directors. From 1990 to 2003, Chris served in various executive and management positions with HealthSouth Corporation where in his last position he served as Senior Vice President of Operations responsible for over 200 facilities located in 10 states. Chris has a BS in Physical Therapy.

What is Christopher J. Reading's net worth?

The estimated net worth of Christopher J. Reading is at least $9.03 million as of May 30th, 2024. Mr. Reading owns 95,838 shares of U.S. Physical Therapy stock worth more than $9,025,064 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Reading may own. Additionally, Mr. Reading receives an annual salary of $1,740,000.00 as CEO at U.S. Physical Therapy. Learn More about Christopher J. Reading's net worth.

How old is Christopher J. Reading?

Mr. Reading is currently 60 years old. There are 5 older executives and no younger executives at U.S. Physical Therapy. Learn More on Christopher J. Reading's age.

What is Christopher J. Reading's salary?

As the CEO of U.S. Physical Therapy, Inc., Mr. Reading earns $1,740,000.00 per year. Learn More on Christopher J. Reading's salary.

How do I contact Christopher J. Reading?

The corporate mailing address for Mr. Reading and other U.S. Physical Therapy executives is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. U.S. Physical Therapy can also be reached via phone at (713) 297-7000 and via email at [email protected]. Learn More on Christopher J. Reading's contact information.

Has Christopher J. Reading been buying or selling shares of U.S. Physical Therapy?

Christopher J. Reading has not been actively trading shares of U.S. Physical Therapy during the last quarter. Most recently, Christopher J. Reading sold 2,900 shares of the business's stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $100.26, for a transaction totalling $290,754.00. Following the completion of the sale, the chief executive officer now directly owns 95,838 shares of the company's stock, valued at $9,608,717.88. Learn More on Christopher J. Reading's trading history.

Who are U.S. Physical Therapy's active insiders?

U.S. Physical Therapy's insider roster includes Harry Chapman (Director), Glenn McDowell (COO), Christopher Reading (CEO), and Graham Reeve (COO). Learn More on U.S. Physical Therapy's active insiders.

Are insiders buying or selling shares of U.S. Physical Therapy?

During the last twelve months, U.S. Physical Therapy insiders bought shares 1 times. They purchased a total of 2,000 shares worth more than $172,180.00. During the last twelve months, insiders at the sold shares 17 times. They sold a total of 31,343 shares worth more than $3,163,034.35. The most recent insider tranaction occured on November, 12th when Director Bernard A Harris Jr sold 2,000 shares worth more than $185,900.00. Insiders at U.S. Physical Therapy own 1.7% of the company. Learn More about insider trades at U.S. Physical Therapy.

Information on this page was last updated on 11/12/2024.

Christopher J. Reading Insider Trading History at U.S. Physical Therapy

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/30/2024Sell2,900$100.26$290,754.0095,838View SEC Filing Icon  
5/28/2024Sell1,100$102.13$112,343.0099,738View SEC Filing Icon  
12/5/2022Sell5,000$90.00$450,000.0074,638View SEC Filing Icon  
12/17/2021Sell12,000$93.89$1,126,680.00View SEC Filing Icon  
12/4/2020Sell6,000$106.67$640,020.00View SEC Filing Icon  
8/19/2019Sell7,000$135.13$945,910.00View SEC Filing Icon  
8/15/2019Sell601$135.39$81,369.39View SEC Filing Icon  
5/21/2019Sell19,860$119.36$2,370,489.60View SEC Filing Icon  
8/14/2018Sell8,768$115.57$1,013,317.76View SEC Filing Icon  
8/7/2018Sell1,232$116.29$143,269.28View SEC Filing Icon  
5/11/2018Sell2,672$92.16$246,251.52View SEC Filing Icon  
5/9/2018Sell13,639$92.01$1,254,924.39View SEC Filing Icon  
11/8/2017Sell15,000$66.52$997,800.00View SEC Filing Icon  
9/19/2016Sell8,000$64.01$512,080.00View SEC Filing Icon  
11/20/2015Sell25,000$52.12$1,303,000.0094,157View SEC Filing Icon  
3/19/2015Sell22,600$48.12$1,087,512.00View SEC Filing Icon  
3/16/2015Sell2,400$49.29$118,296.00View SEC Filing Icon  
11/28/2014Sell9,759$39.29$383,431.11View SEC Filing Icon  
11/25/2014Sell10,241$39.00$399,399.00View SEC Filing Icon  
6/13/2013Sell20,000$29.05$581,000.00View SEC Filing Icon  
See Full Table

Christopher J. Reading Buying and Selling Activity at U.S. Physical Therapy

This chart shows Christopher J Reading's buying and selling at U.S. Physical Therapy by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

U.S. Physical Therapy Company Overview

U.S. Physical Therapy logo
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Read More

Today's Range

Now: $94.17
Low: $90.85
High: $95.44

50 Day Range

MA: $84.68
Low: $77.48
High: $97.10

2 Week Range

Now: $94.17
Low: $76.18
High: $113.63

Volume

224,928 shs

Average Volume

121,116 shs

Market Capitalization

$1.42 billion

P/E Ratio

100.18

Dividend Yield

1.94%

Beta

1.38